custom search
REVERSED
1600 Biotechnology and Organic Chemistry
1611 Ex Parte Kleinwaechter 11225949 - (D) McCOLLUM 103 THE PROCTER & GAMBLE COMPANY PURDY, KYLE A
1612 Ex Parte Guilford et al 11163979 - (D) JENKS 112(2)/103 Daneker, McIntire, Schumm, Prince, Manning & Widmann, P.C. Kishore, Gollamudi
3600 Transportation, Construction, Electronic Commerce, Agriculture, National Security, and License & Review
3694 Ex Parte Hyde et al 12004094 - (D) KIM 103 37 C.F.R. § 41.50(b) 102 IV - SUITER SWANTZ PC LLO ABDI, KAMBIZ
3700 Mechanical Engineering, Manufacturing, and Products & Design
3753 Ex Parte Greene et al 11383513 - (D) WOOD 112(1)/103 MacMillan, Sobanski & Todd, LLC MCCALISTER, WILLIAM M
3761 Ex Parte Tomes et al 11557423 - (D) GRIMES 103 COX SMITH MATTHEWS INCORPORATED HANRAHAN, BENEDICT L
AFFIRMED-IN-PART
1700 Chemical & Materials Engineering
1783 Ex Parte Sturley 10977592 - (D) PRAISS 112(1) 103 Michael D. Wiggins KHATRI, PRASHANT J
AFFIRMED
1600 Biotechnology and Organic Chemistry
1612 Ex Parte Johnson et al 10705481 - (D) JENKS 103 K&L Gates LLP ROBERTS, LEZAH
1643 Ex Parte Karbassi et al 11694370 - (D) FREDMAN 103 MCTAVISH PATENT FIRM Holleran, Anne
“Expected beneficial results are evidence of obviousness of a claimed invention. Just as unexpected beneficial results are evidence of unobviousness.” In re Skoner, 517 F.2d 947, 950 (CCPA 1975).
1700 Chemical & Materials Engineering
1789 Ex Parte Corrigan 11650285 - (D) GARRIS 112(2)/112(1)/103 THE PROCTER & GAMBLE COMPANY KING, FELICIA C
2100 Computer Architecture and Software
2128 Ex Parte Eerd et al 11358597 - (D) WINSOR 102 HEWLETT-PACKARD COMPANY PATEL, SHAMBHAVI K
2174 Ex Parte Retlich 10954128 - (D) DIXON 103 Rockwell Automation, Inc./FY KUMAR, ANIL N
2179 Ex Parte Ahlert et al 11138689 - (D) KOHUT 103 SAP / FINNEGAN, HENDERSON LLP HASSAN, RASHEDUL
2400 Networking, Mulitplexing, Cable, and Security
2487 Ex Parte Kessler et al 09841140 - (D) ZECHER 103 THOMSON MULTIMEDIA LICENSING INC. CZEKAJ, DAVID J
2800 Semiconductors, Electrical and Optical Systems and Components
2824 Ex Parte Roohparvar 11127619 - (D) COURTENAY 112(1)/103 LEFFERT JAY & POLGLAZE, P.A. KING, DOUGLAS
“Combining two embodiments disclosed adjacent to each other in a prior art patent does not require a leap of inventiveness.” Boston Scientific Scimed, Inc. v. Cordis Corp., 554 F.3d 982, 991 (Fed. Cir. 2009).
3600 Transportation, Construction, Electronic Commerce, Agriculture, National Security, and License & Review
3693 Ex Parte MacKouse 11104959 - (D) TURNER 112(1)/103 FOLEY & LARDNER NORMAN, SAMICA L
3700 Mechanical Engineering, Manufacturing, and Products & Design
3761 Ex Parte D'ADDARIO et al 12144932 - (D) PRATS 103 THE PROCTER & GAMBLE COMPANY ZALUKAEVA, TATYANA
